Adam Dinerman

Company: Aro Biotherapeutics

Job title: SVP, Head of CMC

Seminars:

Centyrin-siRNA Conjugates: CMC development path to Clinic 9:00 am

Platform manufacturing considerations for Centyrin-siRNA conjugates CMC development challenges for protein-oligonucleotide conjugates Analytical control strategy considerations and product stability NEW DATARead more

day: Conference Day Two

Roundtable Discussion: Streamlining CMC & Maintaining Purity During Scale Up of RNAi Payloads & Delivery Systems to Streamline RNAi Therapeutic Production & Maximize Clinical Success 9:40 am

Employing analytical methods to measure toxicity and purity of manufactured RNA Increasing efficiency during manufacturing and scale up How different delivery platforms require differing CMC considerationsRead more

day: Conference Day Two